Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

InVivo Biotech Services

InVivo Biotech Services
1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of monoclonal antibodies and recombinant proteins. The company offers a complete range of biotech services, from cloning, screening and recombinant expression of antigens to the generation of hybridoma cell lines and from characterization of antibodies to final production of the developed monoclonal antibodies.

Website
Formerly Known As
Invivo Diagnostica Entwicklungsgesellschaft
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • Neuendorfstr. 24a
  • 16761 Hennigsdorf
  • Germany

+49 03302 000000

InVivo Biotech Services Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore InVivo Biotech Services‘s full profile, request access.

Request full access to PitchBook

InVivo Biotech Services Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ScienCell Research Laboratories Corporation Carlsbad, CA
000000 00000000000 Venture Capital-Backed Quebec, Canada 000.00 0000000000 000.00
000000000000 Corporation Morris Plains, NJ 000 00000 000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
00 000000000000000 Private Equity-Backed Noáin, Spain 000 000.00 000000000000
To view this company’s complete list of competitors, request access »

InVivo Biotech Services Executive Team (2)

Name Title Board
Seat
Contact
Info
Wolfgang Weglohner Ph.D Co-Founder, CSO, Chief Executive Officer and Managing Director
Siegmund Karasch Co-Founder, Managing Director, Chief Operating Officer and Chief Executive Officer